Chu CE - Search Results

1

Re: Vasilis Stavrinides, Francesco Giganti, Bruce Trock, et al. Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study. Eur Urol 2020;78:443-51.

Chu CE, Lonergan PE, Carroll PR. Chu CE, et al. Eur Urol. 2020 Sep;78(3):e110-e111. doi: 10.1016/j.eururo.2020.06.037. Epub 2020 Jul 2. Eur Urol. 2020. PMID: 32622551 No abstract available.

2

Quantified Clinical Risk Change as an End Point During Prostate Cancer Active Surveillance.

Leapman MS, Ameli N, Cooperberg MR, Chu C, Hussein A, Shinohara K, Carroll PR. Leapman MS, et al. Eur Urol. 2017 Sep;72(3):329-332. doi: 10.1016/j.eururo.2016.04.021. Epub 2016 May 4. Eur Urol. 2017. PMID: 27157998

3

Outcomes of men on active surveillance for low-risk prostate cancer at a safety-net hospital.

Osterberg EC, Palmer NRA, Harris CR, Murphy GP, Blaschko SD, Chu C, Allen IE, Cooperberg MR, Carroll PR, Breyer BN. Osterberg EC, et al. Urol Oncol. 2017 Nov;35(11):663.e9-663.e14. doi: 10.1016/j.urolonc.2017.07.003. Epub 2017 Aug 18. Urol Oncol. 2017. PMID: 28826701

4

Editorial Comment.

Carroll PR, Chu C. Carroll PR, et al. J Urol. 2020 Jun;203(6):1121. doi: 10.1097/JU.0000000000000742.01. Epub 2020 Mar 18. J Urol. 2020. PMID: 32186448 No abstract available.

5

Multiparametric Magnetic Resonance Imaging Alone is Insufficient to Detect Grade Reclassification in Active Surveillance for Prostate Cancer.

Chu CE, Lonergan PE, Washington SL, Cowan JE, Shinohara K, Westphalen AC, Carroll PR, Cooperberg MR. Chu CE, et al. Eur Urol. 2020 Oct;78(4):515-517. doi: 10.1016/j.eururo.2020.06.030. Epub 2020 Jul 4. Eur Urol. 2020. PMID: 32631744

6

Editorial Comment.

Chu C, Carroll P. Chu C, et al. J Urol. 2021 Jan;205(1):121. doi: 10.1097/JU.0000000000001241.01. Epub 2020 Nov 2. J Urol. 2021. PMID: 33136472 No abstract available.

7

The Clinical Significance of Multiple Negative Surveillance Prostate Biopsies for Men on Active Surveillance-Does Cancer Vanish or Simply Hide?

Chu CE, Cowan JE, Fasulo V, Washington SL 3rd, de la Calle C, Shoemaker J, Carroll PR. Chu CE, et al. J Urol. 2021 Jan;205(1):109-114. doi: 10.1097/JU.0000000000001339. Epub 2020 Nov 17. J Urol. 2021. PMID: 33198555

8

Liposomal Bupivacaine Decreases Postoperative Length of Stay and Opioid Use in Patients Undergoing Radical Cystectomy.

Chu CE, Law L, Zuniga K, Lin TK, Tsourounis C, Rodriguez-Monguio R, Lazar A, Washington SL 3rd, Cooperberg MR, Greene KL, Carroll PR, Pruthi RS, Meng MV, Chen LL, Porten SP. Chu CE, et al. Urology. 2021 Mar;149:168-173. doi: 10.1016/j.urology.2020.11.036. Epub 2020 Dec 3. Urology. 2021. PMID: 33278460

9

Diagnostic Accuracy and Prognostic Value of Serial Prostate Multiparametric Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer.

Chu CE, Cowan JE, Lonergan PE, Washington SL 3rd, Fasulo V, de la Calle CM, Shinohara K, Westphalen AC, Carroll PR. Chu CE, et al. Eur Urol Oncol. 2022 Oct;5(5):537-543. doi: 10.1016/j.euo.2020.11.007. Epub 2021 Jan 19. Eur Urol Oncol. 2022. PMID: 33483265

10

Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional Imaging.

Ma TM, Gafita A, Shabsovich D, Juarez J, Grogan TR, Thin P, Armstrong W, Sonni I, Nguyen K, Lok V, Reiter RE, Rettig MB, Steinberg ML, Kupelian PA, Yang DD, Muralidhar V, Chu C, Feng F, Savjani R, Deng J, Parikh NR, Nickols NG, Elashoff D, Czernin J, Calais J, Kishan AU. Ma TM, et al. Eur Urol Oncol. 2022 Feb;5(1):100-103. doi: 10.1016/j.euo.2021.01.006. Epub 2021 Feb 16. Eur Urol Oncol. 2022. PMID: 33602654 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

60 results

Search Page